Left ventricular assist device as a bridge to partial left ventriculectomy

Area of Science:

• Cardiovascular Surgery
• Medical Device Technology
• Heart Failure Treatment

Background:

• The first left ventricular assist device (LVAD) was implanted in 1963.
• Cardiovascular research in the 1970s focused on long-term circulatory support.
• Heart transplantation emerged as a viable treatment for heart failure due to improved medical therapies reducing rejection and infection risks.

Purpose of the Study:

• To review the evolving role of left ventricular assist devices (LVADs).
• To assess the use of LVADs as a bridge to transplantation.
• To explore the emerging application of LVADs as a bridge to partial left ventriculectomy (Batista procedure).

Main Methods:

• Historical review of LVAD development and application.
• Analysis of patient outcomes when LVADs are used as a bridge to transplantation.
• Evaluation of early experiences with LVADs preceding partial left ventriculectomy.

Main Results:

• LVADs used as a bridge to transplantation improved patient survival, recovery, ventricular function, and overall health.
• Early results indicate that LVADs as a bridge to partial left ventriculectomy are promising.
• Many patients achieve NYHA functional class I after LVAD support and/or surgery.

Conclusions:

• LVADs have significantly advanced heart failure management, initially as bridges to transplant and now as potential alternatives.
• The use of LVADs in conjunction with partial left ventriculectomy offers a promising option to preserve native heart function.
• This approach may eliminate the need for transplantation in selected patients, conserving donor organs.